NCT07240272

Brief Summary

This clinical trial aims to study whether transcranial alternating current stimulation (tACS) applied to the medial frontal cortex (MFC) can improve speech and cognitive function in people with Parkinson's disease (PD), and to evaluate the safety of tACS. The main goals are to answer the following questions:

  1. 1.Can tACS stimulation of the MFC improve executive functions in people with PD (such as reasoning, planning, inhibition, and complex problem-solving)?
  2. 2.Can it improve the integration of auditory information and speech motor control during communication?
  3. 3.Receive one extra 20-minute session of either real or sham tACS each day for two weeks
  4. 4.Attend clinic visits before stimulation, right after the 2-week period, and again at 1 month and 3 months for assessments and tests
  5. 5.Have their executive function scores, speech performance, and related brain activity recorded

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at P25-P50 for not_applicable parkinson-disease

Timeline
Completed

Started Aug 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2023

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 26, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 20, 2025

Completed
Last Updated

November 20, 2025

Status Verified

September 1, 2025

Enrollment Period

1.8 years

First QC Date

September 26, 2025

Last Update Submit

November 16, 2025

Conditions

Keywords

Parkinson's diseasetranscranial alternating current stimulationmedial frontal cortexexecutive functionsspeech disorder

Outcome Measures

Primary Outcomes (4)

  • Verbal Fluency Test (VFT)

    The VFT assesses abilities such as thought initiation, rapid word retrieval, and cognitive flexibility. It has two parts: 1.Phonemic Fluency Test (PFT), people needed to name as many Chinese words as possible beginning with "fa" or "xiao" within 60 seconds. 2.Semantic Fluency Test (SFT), people needed to name as many items as possible from categories such as "fruits," "vegetables," "animals," and "occupations" within 60 seconds. The number of correct and non-repeated words produced within the time limit were recorded.

    Assessments were completed at baseline, after two weeks of stimulation, and at 1- and 3-month follow-ups.

  • Digit Span Test (DST)

    The DST assesses working memory and selective attention. People repeat a series of numbers in the same order (forward) or reverse order (backward) as spoken by the examiner. The maximum correctly repeated sequence length was recorded.

    Assessments were completed at baseline, after two weeks of stimulation, and at 1- and 3-month follow-ups.

  • Trail Making Test (TMT)

    The TMT assesses complex visual scanning, conceptual tracking, cognitive flexibility and divided attention. It has two parts: TMT-A: People draw a trail by connecting 25 Arabic numbers in ascending order. TMT-B: the trail alternates between connecting 12 Arabic numbers and 12 Chinese characters. The time taken to complete each task is recorded.

    Assessments were completed at baseline, after two weeks of stimulation, and at 1- and 3-month follow-ups.

  • Speech motor integration ability as assessed by a well-established paradigm: frequency-altered feedback (FAF) task

    In the FAF task, participants needed to sit in a sound-attenuated room and produce the vowel /u/ according to instructions. The acoustic signal is recorded and randomly shifted in pitch by an external device. The pitch-shifted voice is then fed back to the participant. This unexpected pitch perturbation elicits either an opposite or a following acoustic compensation response. The amplitude and timing of this response are recorded and used to assess the participant's speech-motor integration ability.

    Assessments were completed at baseline, after two weeks of stimulation, and at 1- and 3-month follow-ups.

Other Outcomes (2)

  • The event-related potentials (ERPs) components recorded by Electroencephalography (EEG)

    Assessments were completed at baseline, after two weeks of stimulation, and at 1- and 3-month follow-ups.

  • The hemodynamic responses in the executive process as assessed by Functional Near-Infrared Spectroscopy (fNIRS)

    Assessments were completed at baseline, after two weeks of stimulation, and at 1- and 3-month follow-ups.

Study Arms (2)

6Hz-group

EXPERIMENTAL
Other: 6Hz-tACS

Sham-group

SHAM COMPARATOR
Other: Sham-tACS

Interventions

tACS applied to the MFC at a frequency of 6 Hz, using a high-definition 1×4 electrode configuration with individualized current intensity, delivered for 20 minutes.

6Hz-group

Except for turning down the current intensity to zero during the 20-minute period, all other parameters are identical to those in 6Hz-group.

Sham-group

Eligibility Criteria

Age35 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of Parkinson's disease.
  • Aged 35-80 years.
  • Absence of non-PD neurological disorders.
  • No hearing impairment, dementia, psychiatric abnormalities, or history of neurosurgical treatment.

You may not qualify if:

  • Pregnancy.
  • Any contraindications to electrical stimulation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Rehabilitation Medicine, The First Affiliated Hospital, Sun Yat-sen University

Guangzhou, Guangdong, 510000, China

Location

MeSH Terms

Conditions

Parkinson DiseaseSpeech Disorders

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesLanguage DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Research Associate

Study Record Dates

First Submitted

September 26, 2025

First Posted

November 20, 2025

Study Start

August 1, 2023

Primary Completion

May 1, 2025

Study Completion

August 1, 2025

Last Updated

November 20, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

All IPD that underlie results in a publication.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE

Locations